UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 8-K
Current Report
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): September 8, 2008
Amedisys, Inc.
(Exact Name of Registrant as specified in its Charter)
Commission File Number: 0-24260
Delaware | 11-3131700 | |
(State or Other Jurisdiction of Incorporation or Organization) | (I.R.S. Employer Identification No.) |
5959 S. Sherwood Forest Blvd., Baton Rouge, LA 70816
(Address of principal executive offices, including zip code)
(225) 292-2031 or (800) 467-2662
(Registrant’s telephone number, including area code)
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
¨ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 7.01. | Regulation FD Disclosure. |
On September 8, 2008, Amedisys, Inc. (the “Company”) issued the press release, which is furnished as Exhibit 99.1 to this Current Report on Form 8-K and that is incorporated by reference into this Item, announcing that the Company has signed a purchase agreement to acquire six home health locations from Home Health Corporation of America, Inc.
On September 8, 2008, the Company issued the press release, which is furnished as Exhibit 99.2 to this Current Report on Form 8-K and that is incorporated by reference into this Item, announcing that its corporate headquarters is fully operational after Hurricane Gustav.
Item 9.01. | Financial Statements and Exhibits. |
(d) | Exhibits. |
See Exhibit Index immediately following signature page.
2
Signature
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Dated: September 8, 2008 | AMEDISYS, INC. | |||
By: | /s/ Dale E. Redman | |||
Name: | Dale E. Redman | |||
Title: | Chief Financial Officer |
3
EXHIBIT INDEX
Exhibit No. | Description | |
99.1 | Press Release issued by Amedisys, Inc. dated September 8, 2008 (furnished only) | |
99.2 | Press Release issued by Amedisys, Inc. dated September 8, 2008 (furnished only) |
4